NLRP3 and atherosclerosis: A microbiota metabolite, Trimethylamine-N-oxide (TMAO), recently has been linked with endothelial inflammation and atherosclerosis, due to its ability to initiate lysosomal dysfunction and NLRP3 inflammasome activation [52].